Report
Michael Waterhouse
EUR 100.00 For Business Accounts Only

Baxter's margin expansion goal looks ambitious, but efforts so far have exceeded our expectations.

Narrow-moat Baxter reported mixed second-quarter results as some lingering hurricane-related customer and supply-related matters led to revenue declines in the medication delivery and nutrition segments. Regardless, stable performance in Baxter’s other segments and revenue contributions from recent acquisitions, including Claris, bolstered the top line with 9% reported growth, or about 4% growth on an organic constant-currency basis. Adjusted operating margin reached 17.1%, or about 70 basis poi...
Underlying
Baxter International Inc.

Baxter International, through its subsidiaries, provides a portfolio of healthcare products, including acute and chronic dialysis therapies; sterile intravenous solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision. The company manages its business based on three geographic segments: Americas (North and South America), Europe, Middle East and Africa and Asia-Pacific.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Michael Waterhouse

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch